A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. 1985

N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin

One hundred and eighty one patients with previously untreated epilepsy were randomised to sodium valproate, phenytoin or carbamazepine as monotherapy and followed up for a median period which ranged from 14 to 24 months. All three drugs were highly effective in the control of generalised seizures but less effective for partial seizures. Excellent or good control was achieved with therapeutic levels of sodium valproate and carbamazepine, but with subtherapeutic levels of phenytoin.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
March 1986, Journal of neurology, neurosurgery, and psychiatry,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
December 2003, Epilepsy & behavior : E&B,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
January 1995, Journal of neurology, neurosurgery, and psychiatry,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
March 1996, Lancet (London, England),
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
August 1981, Epilepsia,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
January 1989, Epilepsy research,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
May 1999, Epilepsia,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
January 1990, Epilepsia,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
March 2003, Acta neurologica Scandinavica,
N Callaghan, and R A Kenny, and B O'Neill, and M Crowley, and T Goggin
January 2009, Clinical neuropharmacology,
Copied contents to your clipboard!